EIM
GRTS

Essex Investment Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Essex Investment Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-80,654
Closed -$1.25M – 518
2018
Q4 		$1.25M Buy
+80,654
New +$1.54M 0.2% 158

Other funds holding GRTS

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Essex Investment Management's GRTS Position: Q1 2019 in Review

Essex Investment Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2019, closing a stake of 80,654 shares — an estimated $1.25M sold.

Essex Investment Management first reported a position in GRTS in Q4 2018 and held it in 1 quarter. The position peaked at $1.25M in Q4 2018. 54 funds tracked by Wall St. Rank hold GRTS as of Q1 2019.

  • Essex Investment Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Essex Investment Management sold 80,654 Gritstone bio, Inc. Common Stock shares in Q1 2019, an estimated $1.25M.
  • Essex Investment Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Essex Investment Management's Gritstone bio, Inc. Common Stock position peaked at $1.25M in Q4 2018.
  • 54 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2019.

Based on Essex Investment Management's 13F filing for Q1 2019, filed 15 May 2019.